Blue Rock Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-30,146	Closed	-$590K	–	72
2020 Q3	$590K	Buy	+30,146	New	+$590K	0.51%	67